NRXN3 belongs to a family of highly polymorphic neuronal‐specific cell surface proteins, and it was reported to promote glioma cell proliferation and migration under the regulation of Fox Q1 (Sun et al., 2013). This evidence concerns the gene NRXN3 and central nervous system cancer.